Video Search Results
RESULTS 1-1 of 1
Gleevec receives US approval as first treatment to reduce risk of cancer returning in patients with gastrointestinal stromal tumors ...
GIST, a life-threatening cancer, recurs in as many as one of two patients; recurrent tumors are often more aggressive than primary tumors
